These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9553446)

  • 1. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk.
    Pfahlberg A; Hassan K; Wille L; Lausen B; Gefeller O
    Public Health Rev; 1997; 25(3-4):309-15. PubMed ID: 9553446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous malignant melanoma in women and the role of oral contraceptives.
    Gefeller O; Hassan K; Wille L
    Br J Dermatol; 1998 Jan; 138(1):122-4. PubMed ID: 9536234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and skin neoplasia.
    Green A
    Contraception; 1991 Jun; 43(6):653-66. PubMed ID: 1868736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of the possible association between oral contraceptives and malignant melanoma.
    Adam SA; Sheaves JK; Wright NH; Mosser G; Harris RW; Vessey MP
    Br J Cancer; 1981 Jul; 44(1):45-50. PubMed ID: 7259960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours.
    Milne R; Vessey M
    Contraception; 1991 Jun; 43(6):667-93. PubMed ID: 1868737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.
    Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
    Ann Oncol; 2009 Feb; 20(2):358-64. PubMed ID: 18725391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
    J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between oral contraceptives and malignant melanomas.
    Stevens RG; Lee JA; Moolgavkar SH
    N Engl J Med; 1980 Apr; 302(17):966. PubMed ID: 7360207
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous melanoma and oral contraceptives: a review of case-control and cohort studies.
    Holly EA
    Recent Results Cancer Res; 1986; 102():108-17. PubMed ID: 3738178
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women.
    Lê MG; Cabanes PA; Desvignes V; Chanteau MF; Mlika N; Avril MF
    Cancer Causes Control; 1992 May; 3(3):199-205. PubMed ID: 1610966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma and oral contraceptive use among women in California.
    Beral V; Ramcharan S; Faris R
    Br J Cancer; 1977 Dec; 36(6):804-9. PubMed ID: 597478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors.
    Zanetti R; Franceschi S; Rosso S; Bidoli E; Colonna S
    Int J Epidemiol; 1990 Sep; 19(3):522-6. PubMed ID: 2262243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use and malignant melanoma in Australia.
    Beral V; Evans S; Shaw H; Milton G
    Br J Cancer; 1984 Nov; 50(5):681-5. PubMed ID: 6498066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study.
    Cervenka I; Mahamat-Saleh Y; Savoye I; Dartois L; Boutron-Ruault MC; Fournier A; Kvaskoff M
    Int J Cancer; 2018 Nov; 143(10):2390-2399. PubMed ID: 29978471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.
    Pladevall-Vila M; Delclos GL; Varas C; Guyer H; Brugués-Tarradellas J; Anglada-Arisa A
    Am J Epidemiol; 1996 Jul; 144(1):1-14. PubMed ID: 8659479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and cancer.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy and ovulation inhibitors as risk factors in malignant melanoma].
    Zaun H
    Hautarzt; 1983 Dec; 34(12):593-5. PubMed ID: 6662722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.